Antibody (1)
온라인 (1)
Rabbit (1)
- (1)
Unconjugated (1)
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Carotuximab | DE-122; TRC-105; Chimeric Antibody TRC-105; NSC#754227 | Phase 2 Clinical | Roswell Park Cancer Institute | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Carcinoma, Hepatocellular; Neoplasm Metastasis; Metastatic breast cancer; Adenoma, Liver Cell; Lung Neoplasms; Fallopian Tube Neoplasms; Glioma; Trophoblastic Tumor, Placental Site; Choriocarcinoma; Ureteral Neoplasms; Astrocytoma; Gliosarcoma; Peritoneal Neoplasms; Ovarian Neoplasms; Brain Neoplasms; Breast Neoplasms; Sarcoma; Oligodendroglioma; Prostatic Neoplasms, Castration-Resistant; Gestational Trophoblastic Disease; Liver Neoplasms, Experimental; Carcinoma, Transitional Cell; Neoplasms; Glioblastoma; Hemangiosarcoma; Trophoblastic Neoplasms; Carcinoma, Renal Cell; Liver Neoplasms; Solid tumours | 상세 |
| STEMVAC | EP-101 | Phase 2 Clinical | Epithany | Triple Negative Breast Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | 상세 |
| ENV-105 | ENV-105 | Phase 2 Clinical | Kairos Pharma Ltd | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung | 상세 |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



